With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

Before buying into the Metsera story, it may be worth waiting for more and later-stage data, as the bar for success has been set high by Eli Lilly's tirzepatide and Novo Nordisk's semaglutide.

Ozempic, a specific brand of the drug semaglutide, often gets used as ... restorative dentistry at the University of Birmingham. Novo Nordisk, which manufactures Ozempic, Wegovy and Saxenda ...

Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

senior vice president and head of Chief Medical Office at Novo Nordisk. “Our broad and robust semaglutide data presented at ECO, including its impact on weight loss in a real-world setting and ...

and Ozempic (semaglutide) for weight loss and type 2 diabetes, respectively, reached DKr73.5bn. Novo Nordisk stated that obesity sales were the main driver – up 65% compared to Q1 2024.

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

Without effective interventions, the global burden of obesity and its complications will continue to rise,” said Stephen Gough, senior vice president and head of Chief Medical Office at Novo Nordisk. ...